Virtue Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$785K Buy
660
+5
+0.8% +$5.11K 0.1% 152
2026
Q1
$581K Buy
655
+51
+8% +$51.7K 0.09% 177
2025
Q4
$653K Sell
604
-671
-53% -$642K 0.1% 142
2025
Q3
$349K Buy
1,275
+479
+60% +$356K 0.06% 223
2025
Q2
$621K Buy
796
+75
+10% +$58.3K 0.11% 132
2025
Q1
$595K Buy
721
+184
+34% +$153K 0.07% 226
2024
Q4
$415K Sell
537
-1,167
-68% -$966K 0.08% 168
2024
Q3
$1.51M Sell
1,704
-129
-7% -$116K 0.3% 56
2024
Q2
$1.62M Sell
1,833
-501
-21% -$401K 0.28% 67
2024
Q1
$1.77M Buy
2,334
+693
+42% +$493K 0.32% 62
2023
Q4
$1.01M Buy
1,641
+3
+0.2% +$1.75K 0.2% 91
2023
Q3
$763K Hold
1,638
0.13% 147
2023
Q2
$763K Buy
+1,638
New +$687K 0.13% 147
2018
Q4
Sell
-15,816
Closed -$1.7M 173
2018
Q3
$1.7M Buy
15,816
+7,647
+94% +$765K 0.36% 76
2018
Q2
$697K Sell
8,169
-1,322
-14% -$109K 0.34% 86
2018
Q1
$761K Buy
9,491
+8,862
+1,409% +$713K 0.4% 76
2017
Q4
$53K Buy
+629
New +$53.5K 0.03% 258

Other funds holding LLY

Virtue Capital Management's LLY Position: Q2 2026 in Review

Virtue Capital Management increased its Eli Lilly (LLY) stake by 0.76% in Q2 2026, buying an estimated $5.11K and bringing the position to 660 shares worth $785K. The position accounts for 0.1% of the portfolio, ranked #152.

Virtue Capital Management first reported a position in LLY in Q4 2017 and has held it in 17 quarters since. The position peaked at $1.77M in Q1 2024. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Virtue Capital Management held 660 shares of Eli Lilly worth $785K as of Q2 2026.
  • Virtue Capital Management bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.1% of Virtue Capital Management's portfolio in Q2 2026, its #152 holding.
  • Virtue Capital Management first reported a position in Eli Lilly in Q4 2017 and has held it in 17 quarters since.
  • Virtue Capital Management's Eli Lilly position peaked at $1.77M in Q1 2024.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.